CN Stock MarketDetailed Quotes

600557 Jiangsu Kanion Pharmaceutical

Watchlist
  • 17.57
  • +0.37+2.15%
Market Closed Jun 4 15:00 CST
10.22BMarket Cap18.81P/E (TTM)

Jiangsu Kanion Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
0.48%1.36B
11.88%4.87B
11.86%3.5B
21.74%2.55B
25.39%1.35B
19.25%4.35B
20.97%3.13B
18.54%2.1B
25.16%1.08B
20.34%3.65B
Operating revenue
0.48%1.36B
11.88%4.87B
11.86%3.5B
21.74%2.55B
25.39%1.35B
19.25%4.35B
20.97%3.13B
18.54%2.1B
25.16%1.08B
20.34%3.65B
Other operating revenue
----
2.98%28.27M
----
-28.18%14.4M
----
-21.44%27.46M
----
1.96%20.04M
----
-26.30%34.95M
Total operating cost
-0.30%1.19B
10.61%4.36B
10.50%3.1B
20.39%2.23B
25.15%1.19B
18.05%3.94B
20.38%2.81B
18.13%1.85B
24.64%951.28M
22.49%3.34B
Operating cost
2.48%345.11M
3.17%1.25B
0.48%919.75M
7.31%639.57M
9.42%336.77M
18.44%1.21B
20.89%915.38M
15.93%596.02M
23.51%307.78M
24.75%1.03B
Operating tax surcharges
13.64%21.55M
2.20%74.78M
2.80%54.59M
7.56%39.43M
4.83%18.96M
20.36%73.18M
22.13%53.11M
22.64%36.66M
25.20%18.08M
33.73%60.8M
Operating expense
-14.41%508.86M
3.70%1.94B
15.46%1.48B
26.32%1.09B
33.93%594.55M
17.99%1.87B
19.64%1.28B
18.72%861.83M
22.83%443.92M
21.56%1.58B
Administration expense
111.89%116.51M
83.04%347.04M
22.52%149.54M
29.09%109.95M
48.60%54.99M
16.84%189.6M
7.67%122.06M
8.97%85.18M
18.66%37.01M
5.72%162.27M
Financial expense
-179.01%-9.14M
-160.96%-23.06M
-191.97%-15.3M
-261.57%-7.87M
-1,217.02%-3.28M
-207.70%-8.84M
-171.95%-5.24M
-140.14%-2.18M
-91.24%293.22K
-63.35%8.2M
-Interest expense (Financial expense)
----
----
----
-97.65%32.78K
----
-82.84%1.91M
-83.83%1.41M
-76.97%1.4M
-61.53%1.41M
-52.47%11.15M
-Interest Income (Financial expense)
-168.99%-9.33M
-119.37%-24.45M
-122.26%-16.39M
-94.93%-8.35M
-126.37%-3.47M
-211.16%-11.15M
-290.51%-7.38M
-335.70%-4.28M
-245.00%-1.53M
-139.01%-3.58M
Research and development
8.24%204.12M
27.40%771.69M
16.67%510.01M
31.02%363.45M
30.78%188.58M
21.29%605.73M
29.78%437.12M
28.01%277.4M
39.18%144.2M
31.27%499.39M
Credit Impairment Loss
-109.94%-690.85K
94.34%-120.01K
-3.06%-1.1M
-595.56%-1.87M
2,294.65%6.95M
-472.21%-2.12M
-452.56%-1.07M
153.05%377.55K
115.27%290.21K
152.00%569.71K
Asset Impairment Loss
----
-631.95%-2.77M
----
----
----
-64.55%521K
----
----
----
-47.36%1.47M
Other net revenue
-7.39%10.59M
22.79%55.9M
111.34%52.86M
49.94%22.26M
45.42%11.43M
10.53%45.52M
58.26%25.01M
46.05%14.84M
55.79%7.86M
-9.05%41.19M
Invest income
1,246.80%6.03M
252.36%14.79M
98.50%6.61M
-63.33%932.07K
-60.25%447.98K
3.51%4.2M
34.33%3.33M
37.03%2.54M
45.20%1.13M
49.61%4.06M
-Including: Investment income associates
----
-49.42%20.9K
-1.90%20.66K
-1.90%20.66K
----
109.86%41.32K
-5.00%21.06K
-5.00%21.06K
----
-22.93%19.69K
Asset deal income
---55.32K
-45.12%757.74K
-102.44%-28.87K
-12,033.04%-28.87K
----
42.98%1.38M
-16.35%1.18M
-100.41%-237.91
100.71%24.23
425.45%965.77K
Other revenue
31.36%5.3M
4.08%43.24M
119.68%47.39M
94.76%23.23M
-37.38%4.04M
21.74%41.54M
78.20%21.57M
33.05%11.93M
4.38%6.44M
-17.12%34.13M
Operating profit
5.33%182.59M
23.96%563.79M
30.17%447.06M
33.11%342.23M
28.22%173.36M
29.58%454.81M
28.38%343.45M
23.00%257.11M
30.46%135.21M
-0.12%350.98M
Add:Non operating Income
353.86%954.06K
84.80%6.16M
-55.45%1.4M
-61.85%1.08M
51.13%210.21K
432.47%3.33M
561.12%3.15M
407.81%2.83M
-58.65%139.09K
-77.47%625.53K
Less:Non operating expense
306.21%5.95M
52.64%18.96M
33.73%13.42M
-2.11%8.56M
-64.06%1.46M
-46.77%12.42M
-43.58%10.04M
-49.29%8.75M
47.64%4.07M
-60.95%23.34M
Total profit
3.19%177.6M
23.62%550.98M
29.26%435.04M
33.26%334.75M
31.11%172.11M
35.78%445.72M
34.51%336.56M
30.60%251.2M
29.70%131.27M
11.49%328.27M
Less:Income tax cost
4.47%28.03M
3.52%3.93M
43.17%75.29M
30.19%51.86M
28.43%26.83M
-2.99%3.8M
32.13%52.59M
29.76%39.83M
32.94%20.89M
-80.80%3.92M
Net profit
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
29.10%110.38M
18.36%324.35M
Net profit from continuing operation
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
29.10%110.38M
18.36%324.35M
Less:Minority Profit
-60.28%1.52M
38.47%10.32M
287.96%10.23M
2,842.63%7.17M
875.32%3.83M
95.72%7.45M
-19.81%2.64M
-88.52%243.6K
-73.76%393.08K
-65.71%3.81M
Net profit of parent company owners
4.67%148.04M
23.54%536.73M
24.24%349.53M
30.60%275.72M
28.60%141.44M
35.54%434.47M
35.83%281.34M
32.35%211.12M
30.94%109.99M
21.92%320.54M
Earning per share
Basic earning per share
4.00%0.26
24.00%0.93
24.49%0.61
27.03%0.47
31.58%0.25
33.93%0.75
36.11%0.49
32.14%0.37
26.67%0.19
27.27%0.56
Diluted earning per share
4.17%0.25
24.00%0.93
22.45%0.6
27.03%0.47
26.32%0.24
33.93%0.75
36.11%0.49
32.14%0.37
26.67%0.19
27.27%0.56
Other composite income
Total composite income
2.96%149.57M
23.79%547.05M
26.69%359.75M
33.84%282.89M
31.61%145.27M
36.25%441.92M
34.96%283.97M
30.77%211.36M
29.10%110.38M
18.36%324.35M
Total composite income of parent company owners
4.67%148.04M
23.54%536.73M
24.24%349.53M
30.60%275.72M
28.60%141.44M
35.54%434.47M
35.83%281.34M
32.35%211.12M
30.94%109.99M
21.92%320.54M
Total composite income of minority owners
-60.28%1.52M
38.47%10.32M
287.96%10.23M
2,842.63%7.17M
875.32%3.83M
95.72%7.45M
-19.81%2.64M
-88.52%243.6K
-73.76%393.08K
-65.71%3.81M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 0.48%1.36B11.88%4.87B11.86%3.5B21.74%2.55B25.39%1.35B19.25%4.35B20.97%3.13B18.54%2.1B25.16%1.08B20.34%3.65B
Operating revenue 0.48%1.36B11.88%4.87B11.86%3.5B21.74%2.55B25.39%1.35B19.25%4.35B20.97%3.13B18.54%2.1B25.16%1.08B20.34%3.65B
Other operating revenue ----2.98%28.27M-----28.18%14.4M-----21.44%27.46M----1.96%20.04M-----26.30%34.95M
Total operating cost -0.30%1.19B10.61%4.36B10.50%3.1B20.39%2.23B25.15%1.19B18.05%3.94B20.38%2.81B18.13%1.85B24.64%951.28M22.49%3.34B
Operating cost 2.48%345.11M3.17%1.25B0.48%919.75M7.31%639.57M9.42%336.77M18.44%1.21B20.89%915.38M15.93%596.02M23.51%307.78M24.75%1.03B
Operating tax surcharges 13.64%21.55M2.20%74.78M2.80%54.59M7.56%39.43M4.83%18.96M20.36%73.18M22.13%53.11M22.64%36.66M25.20%18.08M33.73%60.8M
Operating expense -14.41%508.86M3.70%1.94B15.46%1.48B26.32%1.09B33.93%594.55M17.99%1.87B19.64%1.28B18.72%861.83M22.83%443.92M21.56%1.58B
Administration expense 111.89%116.51M83.04%347.04M22.52%149.54M29.09%109.95M48.60%54.99M16.84%189.6M7.67%122.06M8.97%85.18M18.66%37.01M5.72%162.27M
Financial expense -179.01%-9.14M-160.96%-23.06M-191.97%-15.3M-261.57%-7.87M-1,217.02%-3.28M-207.70%-8.84M-171.95%-5.24M-140.14%-2.18M-91.24%293.22K-63.35%8.2M
-Interest expense (Financial expense) -------------97.65%32.78K-----82.84%1.91M-83.83%1.41M-76.97%1.4M-61.53%1.41M-52.47%11.15M
-Interest Income (Financial expense) -168.99%-9.33M-119.37%-24.45M-122.26%-16.39M-94.93%-8.35M-126.37%-3.47M-211.16%-11.15M-290.51%-7.38M-335.70%-4.28M-245.00%-1.53M-139.01%-3.58M
Research and development 8.24%204.12M27.40%771.69M16.67%510.01M31.02%363.45M30.78%188.58M21.29%605.73M29.78%437.12M28.01%277.4M39.18%144.2M31.27%499.39M
Credit Impairment Loss -109.94%-690.85K94.34%-120.01K-3.06%-1.1M-595.56%-1.87M2,294.65%6.95M-472.21%-2.12M-452.56%-1.07M153.05%377.55K115.27%290.21K152.00%569.71K
Asset Impairment Loss -----631.95%-2.77M-------------64.55%521K-------------47.36%1.47M
Other net revenue -7.39%10.59M22.79%55.9M111.34%52.86M49.94%22.26M45.42%11.43M10.53%45.52M58.26%25.01M46.05%14.84M55.79%7.86M-9.05%41.19M
Invest income 1,246.80%6.03M252.36%14.79M98.50%6.61M-63.33%932.07K-60.25%447.98K3.51%4.2M34.33%3.33M37.03%2.54M45.20%1.13M49.61%4.06M
-Including: Investment income associates -----49.42%20.9K-1.90%20.66K-1.90%20.66K----109.86%41.32K-5.00%21.06K-5.00%21.06K-----22.93%19.69K
Asset deal income ---55.32K-45.12%757.74K-102.44%-28.87K-12,033.04%-28.87K----42.98%1.38M-16.35%1.18M-100.41%-237.91100.71%24.23425.45%965.77K
Other revenue 31.36%5.3M4.08%43.24M119.68%47.39M94.76%23.23M-37.38%4.04M21.74%41.54M78.20%21.57M33.05%11.93M4.38%6.44M-17.12%34.13M
Operating profit 5.33%182.59M23.96%563.79M30.17%447.06M33.11%342.23M28.22%173.36M29.58%454.81M28.38%343.45M23.00%257.11M30.46%135.21M-0.12%350.98M
Add:Non operating Income 353.86%954.06K84.80%6.16M-55.45%1.4M-61.85%1.08M51.13%210.21K432.47%3.33M561.12%3.15M407.81%2.83M-58.65%139.09K-77.47%625.53K
Less:Non operating expense 306.21%5.95M52.64%18.96M33.73%13.42M-2.11%8.56M-64.06%1.46M-46.77%12.42M-43.58%10.04M-49.29%8.75M47.64%4.07M-60.95%23.34M
Total profit 3.19%177.6M23.62%550.98M29.26%435.04M33.26%334.75M31.11%172.11M35.78%445.72M34.51%336.56M30.60%251.2M29.70%131.27M11.49%328.27M
Less:Income tax cost 4.47%28.03M3.52%3.93M43.17%75.29M30.19%51.86M28.43%26.83M-2.99%3.8M32.13%52.59M29.76%39.83M32.94%20.89M-80.80%3.92M
Net profit 2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M29.10%110.38M18.36%324.35M
Net profit from continuing operation 2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M29.10%110.38M18.36%324.35M
Less:Minority Profit -60.28%1.52M38.47%10.32M287.96%10.23M2,842.63%7.17M875.32%3.83M95.72%7.45M-19.81%2.64M-88.52%243.6K-73.76%393.08K-65.71%3.81M
Net profit of parent company owners 4.67%148.04M23.54%536.73M24.24%349.53M30.60%275.72M28.60%141.44M35.54%434.47M35.83%281.34M32.35%211.12M30.94%109.99M21.92%320.54M
Earning per share
Basic earning per share 4.00%0.2624.00%0.9324.49%0.6127.03%0.4731.58%0.2533.93%0.7536.11%0.4932.14%0.3726.67%0.1927.27%0.56
Diluted earning per share 4.17%0.2524.00%0.9322.45%0.627.03%0.4726.32%0.2433.93%0.7536.11%0.4932.14%0.3726.67%0.1927.27%0.56
Other composite income
Total composite income 2.96%149.57M23.79%547.05M26.69%359.75M33.84%282.89M31.61%145.27M36.25%441.92M34.96%283.97M30.77%211.36M29.10%110.38M18.36%324.35M
Total composite income of parent company owners 4.67%148.04M23.54%536.73M24.24%349.53M30.60%275.72M28.60%141.44M35.54%434.47M35.83%281.34M32.35%211.12M30.94%109.99M21.92%320.54M
Total composite income of minority owners -60.28%1.52M38.47%10.32M287.96%10.23M2,842.63%7.17M875.32%3.83M95.72%7.45M-19.81%2.64M-88.52%243.6K-73.76%393.08K-65.71%3.81M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg